After nearly two years, COVID-19 continues to impact countries around the world. The pandemic has also highlighted the vital role of healthcare companies in developing and ensuring the equitable distribution of life-saving medicines.   Among those involved in the effort to stop the spread and negative effects of coronavirus is global pharmaceutical firm Merck, Sharp, and…

In an industry as dynamic and competitive as healthcare, standing out requires outstanding ingenuity, while still maintaining a dedication to patient wellbeing and care. For California-headquartered biopharmaceutical company Amgen, which last year celebrated 40 years of providing innovative and life-changing treatments to patients, being a leader is baked into its DNA. Over that period, 70%…

Research-based biopharmaceutical multinational AstraZeneca, one of the earliest healthcare companies to enter the Taiwan market, has been working to deliver the best in patient care in Taiwan for over 70 years. The company’s dedication to advancing medical science is reflected in its innovation and outstanding performance in R&D. It is also focused on “beyond the…

Finding effective solutions to the world’s health issues requires novel, holistic approaches and collaborative ingenuity. Healthcare companies must therefore increasingly shift their focus to the research and development of medical technologies, biopharmaceuticals, and innovative therapies to treat conditions and diseases that are difficult or nearly impossible to tackle using traditional medicines. Such a reality is…

Pfizer has called on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic,” Dr. Albert Bourla, the company’s Chairman and CEO, said in a statement. “Many companies, including Pfizer, are working…